Cynata Therapeutics Limited ( (AU:CYP) ) has issued an announcement. Cynata Therapeutics Limited announced it received a $1.7 million R&D Tax Incentive Refund for the 2024/2025 financial year. This ...

Dr Paul O’Keeffe, new role as head of education and research at Airfield Estate, Dublin’s 38-acre urban farm and sustainable ...

Mesoblast’s Ryoncil ® (remestemcel-L-rknd) for the treatment of steroid-refractory acute graft versus host disease (SR-aGvHD) in pediatric patients 2 months and older is the first FDA-approved ...

In an increasingly fragmented literary landscape, few emerging voices manage to articulate the complexity of contemporary lived ...

Cynata Therapeutics Limited (ASX: CYP), a clinical-stage biotechnology company specialising in cell therapeutics, announced ...

On track for top-line trial results in the third quarter of 2026 from pivotal Phase 2b clinical trial ELPIS II. ELPIS II is evaluating ...

Veterans of the U.S. military face unique respiratory risks, but physicians can guide them through care with the aid of the Department of Veterans Affairs, according to a presentation at the CHEST ...

Title: Lead Academy U19 Physiotherapist Department: Academy Medical Department Location: Oxford United Training Centre, ...